DNA vaccines for therapy of tuberculosis: Where are we now?

Vaccine

Volumn 24, Issue 12, 2006, Pages 1983-1989

  Lowrie, Douglas B ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Animal models; DNA vaccines; Tuberculosis

Indexed keywords

85A ANTIGEN; 85B ANTIGEN; ALPHA INTERFERON; ANTIGEN 10; ANTIINFECTIVE AGENT; BCG VACCINE; DEXAMETHASONE; DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; ISONIAZID; MOXIFLOXACIN; MPT64 VACCINE; MPT70 VACCINE; MYCOBACTERIUM ANTIGEN; PSTS 3 ANTIGEN; PYRAZINAMIDE; RIFAMPICIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; COLONY FORMING UNIT; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFECT; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOTHERAPY; MOUSE STRAIN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANIMALS; COMBINED MODALITY THERAPY; DNA, BACTERIAL; DRUG THERAPY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 32844455083     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.010     Document Type: Review

References (55)

1. D.B. Lowrie, R.E. Tascon, M.J. Colston, and C.L. Silva Towards a DNA vaccine against tuberculosis Vaccine 12 1994 1537 1540
2. M.A. Skinner, B.M. Buddle, D.N. Wedlock, D. Keen, G.W. de Lisle, and R.E. Tascon A DNA prime-mycobactetium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Infect Immun 71 9 2003 4901 4907
3. M.A. Skinner, A.J. Ramsay, G.S. Buchan, D.L. Keen, C. Ranasinghe, and L. Slobbe A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis Immunology 108 4 2003 548 555
4. H.M. Vordermeier, D.B. Lowrie, and R.G. Hewinson Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting Vet Microbiol 93 4 2003 349 359
5. M. Ruberti, K.D. Lima, S.A. Dos Santos, I.T. Brandao, E.G. Soares, and C.L. Silva Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention J Drug Target 12 4 2004 195 203
6. A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T.H. Ottenhoff, and W. Dalemans Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting Infect Immun 69 5 2001 3041 3047
7. J. Donnelly, K. Berry, and J.B. Ulmer Technical and regulatory hurdles for DNA vaccines Int J Parasitol 33 5-6 2003 457 467
8. C.L. Silva, and D.B. Lowrie Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis Infect Immun 68 2000 3269 3274
9. V.L. Bonato, V.M. Lima, R.E. Tascon, D.B. Lowrie, and C.L. Silva Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice Infect Immun 66 1 1998 169 175
10. D.B. Lowrie, R.E. Tascon, V.L. Bonato, V.M. Lima, L.H. Faccioli, and E. Stavropoulos Therapy of tuberculosis in mice by DNA vaccination Nature 400 6741 1999 269 271
11. J. Turner, E.R. Rhoades, M. Keen, J.T. Belisle, A.A. Frank, and I.M. Orme Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode Infec Immun 68 2000 1706 1709
12. J.L. Taylor, O.C. Turner, R.J. Basaraba, J.T. Belisle, K. Huygen, and I.M. Orme Pulmonary necrosis resulting from DNA vaccination against tuberculosis Infect Immun 71 4 2003 2192 2198
13. J.L. Taylor, D.J. Ordway, J. Troudt, M. Gonzalez-Juarrero, R.J. Basaraba, and I.M. Orme Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA Infect Immun 73 8 2005 5189 5193
14. C.L. Silva, V.L.D. Bonato, A.A.M. Coelho-Castelo, A.O. De Souza, S.A. Santos, and K.M. Lima Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice Gene Ther 12 3 2005 281 287
15. Rook GAW, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 5:661-7.
16. G.A.W. Rook, R. Hernandez-Pando, K. Dheda, and G.T. Seah IL-4 in tuberculosis: implications for vaccine design Trends Immunol 25 9 2004 483 488
17. G.N. Neigh, S.L. Bowers, B. Korman, and R.J. Nelson Housing environment alters delayed-type hypersensitivity and corticosterone concentrations of individually housed male C57BL/6 mice Anim Welf 14 3 2005 249 257
18. J.D. Karp, N. Cohen, and J.A. Moynihan Quantitative differences in interleukin-2 and interleukin-4 production by antigen-stimulated splenocytes from individually- and group-housed mice Life Sci 55 10 1994 789 795
19. J. Bohannon Animal models. Can a mouse be standardized? Science 298 5602 2002 2320 2321
20. G. Delogu, A. Li, C. Repique, F. Collins, and S.L. Morris DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis Infect Immun 70 1 2002 292 302
21. C.J. Repique, A. Li, F.M. Collins, and S.L. Morris DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge Infect Immun 70 7 2002 3318 3323
22. S.C. Derrick, C. Repique, P. Snoy, A.L. Yang, and S. Morris Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis Infect Immun 72 3 2004 1685 1692
23. S.J. Ha, B.Y. Jeon, S.C. Kim, D.J. Kim, M.K. Song, and Y.C. Sung Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis Gene Ther 10 18 2003 1592 1599
24. S.J. Ha, B.Y. Jeon, J.I. Youn, S.C. Kim, S.N. Cho, and Y.C. Sung Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis Gene Ther 12 7 2005 634 638
25. D.B. Lowrie, and C.L. Silva Enhancement of immunocompetence in tuberculosis by DNA vaccination Vaccine 18 2000 1712 1716
26. R.M. Warren, T.C. Victor, E.M. Streicher, M. Richardson, N. Beyers, and N.C.G. van Pittius Patients with active tuberculosis often have different strains in the same sputum specimen Am J Respir Crit Care Med 169 5 2004 610 614
27. C.L. Cosma, O. Humbert, and L. Ramakrishnan Superinfecting mycobacteria home to established tuberculous granulomas Nat Immunol 5 8 2004 828 835
28. D.Y. Zhu, S. Jiang, and X.D. Luo Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection Vaccine 23 37 2005 4619 4624
29. V.L.D. Bonato, E.D.C. Goncalves, E.G. Soares, R.R.S. Junior, A. Sartori, and A.A.M. Coelho-Castelo Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8(+) cells, interferon-gamma recovery and reduction of lung injury Immunology 113 1 2004 130 138
30. E. Nuermberger, S. Tyagi, K.N. Williams, I. Rosenthal, W.R. Bishai, and J.H. Grosset Rifapentine, moxifloxacin or DNA vaccine improves treatment of latent tuberculosis in a mouse model Am J Respir Crit Care Med 2005 [200507-1047OC]
31. S.R. Krutzik, and R.L. Modlin The role of Toll-like receptors in combating mycobacteria Semin Immunol 16 1 2004 35 41
32. J. Indrigo, R.L. Hunter, and J.K. Actor Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages Microbiology-SGM 148 2002 1991 1998
33. V. Nagabhushanam, A. Solache, L.M. Ting, C.J. Escaron, J.Y. Zhang, and J.D. Ernst Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma J Immunol 171 9 2003 4750 4757
34. A.K. Shabaana, K. Kulangara, I. Semac, Y. Parel, S. Ilangumaran, and K. Dharmalingam Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling Cell Mol Life Sci 62 2 2005 179 187
35. V.J. Quesniaux, D.M. Nicolle, D. Torres, L. Kremer, Y. Guerardel, and J. Nigou Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent- negative regulation of proinflammatory cytokines by mycobacterial lipomannans J Immunol 172 7 2004 4425 4434
36. S.M. Fortune, A. Solache, A. Jaeger, P.J. Hill, J.T. Belisle, and B.R. Bloom Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms J Immunol 172 10 2004 6272 6280
37. S.L. Baldwin, C. Dsouza, A.D. Roberts, B.P. Kelly, A.A. Frank, and M.A. Lui Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis Infect Immun 66 1998 2951 2959
38. M.A. Chambers, A. Williams, G. Hatch, D. Gavier-Widen, G. Hall, and K. Huygen Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection Mycobacterium bovis Infect Immun 70 4 2002 2159 2165
39. G. Kaplan, F.A. Post, A.L. Moreira, H. Wainwright, B.N. Kreiswirth, and M. Tanverdi Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity Infect Immun 71 12 2003 7099 7108
40. H. Tomioka Adjunctive immunotherapy of mycobacterial infections Curr Pharm Des 10 26 2004 3297 3312
41. J. Stanford, C. Stanford, and J. Grange Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis Front Biosci 9 2004 1701 1719
42. J.L. Johnson, A.J. Nunn, P.B. Fourie, L.R. Ormerod, R.D. Mugerwa, and A. Mwinga Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis Int J Tuberc Lung Dis 8 11 2004 1348 1354
43. A. Mwinga, A. Nunn, B. Ngwira, C. Chintu, D. Warndorff, and P. Fine Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial Lancet 360 9339 2002 1050 1055
44. E. Davila, M.G. Velez, C.J. Heppelmann, and E. Celis Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment Blood 100 7 2002 2537 2545
45. R.E. Tascon, S. Ragno, D.B. Lowrie, and M.J. Colston Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8(+) T cells Immunology 99 2000 1 7
46. D. Palliser, Q. Huang, N. Hacohen, S.P. Lamontagne, E. Guillen, and R.A. Young A role for toll-like receptor 4 in dendritic cell activation and cytolytic CD8+T cell differentiation in response to a recombinant heat shock fusion protein J Immunol 172 5 2004 2885 2893
47. K. Chen, J.H. Lu, L. Wang, and Y.H. Gan Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling J Leukoc Biol 75 2 2004 260 266
48. D. Palliser, E. Guillen, M.D. Ju, and H.N. Eisen Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells J Immunol 174 4 2005 1879 1887
49. R.J. Binder, R. Vatner, and P. Srivastava The heat-shock protein receptors: some answers and more questions Tissue Antigens 64 4 2004 442 451
50. G.A.W. Rook, K. Dheda, and A. Zumla Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 23 17-18 2005 2115 2120
51. W. van Eden, R. van der Zee, and B. Prakken Heat-shock proteins induce T-cell regulation of chronic inflammation Nat Rev Immunol 5 4 2005 318 330
52. F.J. Quintana, P. Carmi, F. Mor, and I.R. Cohen Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein Arthritis Rheum 50 11 2004 3712 3720
53. F.J. Quintana, P. Carmi, F. Mor, and I.R. Cohen DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide J Immunol 171 7 2003 3533 3541
54. A.L. Moreira, L. Tsenova, M.H. Aman, L.G. Bekker, S. Freeman, and B. Mangaliso Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice Infect Immun 70 4 2002 2100 2107
55. T.M. Doherty Real world TB vaccines: clinical trials in TB-endemic regions Vaccine 23 17-18 2005 2109 2114